Nov
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Nov 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Mar
7
Wed
E2E Design Lab
Mar 7 – Mar 8 all-day

The Clinical and Translational Science Award (CTSA) program’s Trial Innovation Network (TIN) offers support for efficacy to effectiveness (E2E) trials, or trials where a successful efficacy study transitions seamlessly into an effectiveness trial. Studies like these are important because they address safety gaps, streamline the trial process, and offer an opportunity to better understand how a treatment will work in real-world clinical settings.

Learn how to boost your trial design at the two-day E2E Design Lab workshop March 7-8 in Boston, MA, offered by CTSA’s Massachusetts Institute of Technology (MIT) NEWDIGS program in collaboration with the JHU-Tufts Trial Innovation Center. The interactive event will dive into the process of planning a Phase 2 or Phase 3 E2E multi-center trial to help you improve your research and study design.

Learn More Here

Source: Trial Innovation Network

Mar
29
Thu
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Jul
30
Mon
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Jul 30 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS